Sgd Pharma

SGD Pharma, based in FR and operating in the rubber and plastic products industry, has outlined its climate commitments and reported its carbon emissions.

For the 2025 reporting year, SGD Pharma's total carbon emissions amounted to approximately 477.5 billion kg CO2e. This includes Scope 1 emissions of about 125.0 billion kg CO2e, Scope 2 emissions of approximately 33.8 billion kg CO2e, and Scope 3 emissions of roughly 318.8 billion kg CO2e.

In 2024, the company's total emissions were approximately 490.4 billion kg CO2e, comprising Scope 1 emissions of about 121.6 billion kg CO2e, Scope 2 emissions of approximately 59.9 billion kg CO2e, and Scope 3 emissions of roughly 328.9 billion kg CO2e.

SGD Pharma's climate strategy includes significant reduction targets. The company aims to achieve carbon neutrality by 2050. Furthermore, SGD Pharma's plants in France, Germany, India, and China are committed to reducing Scope 1 and 2 CO2 emissions by 35% by 2030 and by 65% by 2040, using a 2020 baseline. A separate commitment aims for a 42% reduction in Scope 1 and 2 CO2 emissions by 2030, compared to 2022 levels, aligning with a 1.5°C climate threshold. Looking further ahead, SGD Pharma is targeting a 65% reduction in CO2 emissions by 2040.